NCT01320761View on ClinicalTrials.gov

A Study to Assess Injection Comfort of Two Formulations of ATX-101

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

Not specified

Conditions
Healthy
Interventions
DRUG

ATX-101-BA-free

ATX-101-BA-free

DRUG

ATX-101-BA

ATX-101-BA

Trial Locations (2)

68144

Joel Schlessinger, M.D., Omaha

75093

Jeffrey M. Adelglass, M.D., Plano

Sponsors
All Listed Sponsors
lead

Kythera Biopharmaceuticals

INDUSTRY

NCT01320761 - A Study to Assess Injection Comfort of Two Formulations of ATX-101 | Biotech Hunter | Biotech Hunter